Alternative Macrophage Activation and Metabolism
Justin Iver Odegaard, Ajay Chawla · Annual Review of Pathology Mechanisms of Disease · 2011
Obesity and its attendant metabolic disorders represent the great public health challenge of our time. Recent evidence suggests that onset of inflammation in metabolic tissues pathogenically links obesity to insulin resistance and type 2 diabetes. In this review, we briefly summarize the extant literature, paying special attention to the central role of the tissue-associated macrophage in the initiation of metabolic inflammation. We argue that rather than representing simple inflammatory disease, obesity and metabolic syndrome represent derangements in macrophage activation with concomitant loss of metabolic coordination. As such, the sequelae of obesity are as much products of the loss of positive macrophage influences as they are of the presence of deleterious inflammation. The therapeutic implications of this conclusion are profound because they suggest that pharmacologic targeting of macrophage activation, rather than simply inflammation, might be efficacious in treating this global epidemic.
Cited by 639 works. doi:10.1146/annurev-pathol-011110-130138
Authors
References
- Actual Causes of Death in the United States
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- Obesity is associated with macrophage accumulation in adipose tissue
- Actual Causes of Death in the United States, 2000
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
- Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
- Inflammation and metabolic disorders
- Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? 1962.
- Alternative activation of macrophages
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance